Nanomedicine News

RSS

Novavax' Nanoparticle Vaccine for Infant Protection via Maternal Immunization Granted FDA Fast Track Designation

Novavax, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Novavax' RSV F-Protein nanoparticle vaccine candidate (RSV F vaccine) for protection of infants via maternal immunization.

From Novavax Inc. 24 Nov 2014

Nanophosphor Biomarker Lights Up On Detecting Tumour Cells

Nanyang Technological University (NTU) has invented a unique biomarker with two exceptional functions.

24 Nov 2014

Iron-Oxide Nanoparticles Can Successfully Detect Ovarian Tumors In Vivo

Google’s latest search initiative isn’t taking place online, but in the human body instead. On October 28, The Wall Street Journal reported that the Internet giant wants to design tiny magnetic particles to patrol the body for signs of cancer and other diseases. Google said its nanoparticles, less than one-thousandth the width of a red blood cell, would seek out and attach themselves to cells, proteins or other molecules inside the body.

From Manhattan Scientifics Inc. 24 Nov 2014

NanoViricides’ Injectable FluCide Drug among ‘Top Ten Infectious Diseases Projects to Watch’

NanoViricides, Inc., announced today that its “Injectable FluCide™” drug candidate for severe influenza has been chosen as one of the “Top Ten Infectious Diseases Projects to Watch” by a panel of industry experts assembled by Informa and the publishers of In Vivo, Startup and The Pink Sheet.

From NanoViricides, Inc 21 Nov 2014

BIND Reports Positive Results from BIND-014 Polymeric Nanoparticle Phase 2 Study in NSCLC

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today presented positive results from its ongoing Phase 2 study of BIND-014 in non-small cell lung cancer (NSCLC), demonstrating it has met the primary objective in the once every three weeks (Q3W) arm as measured by overall response rate (ORR).

20 Nov 2014

Biodegradable Gelatin Embedded with Nano-Sized Silicate Discs Aids in Blood Coagulation

Internal bleeding is a leading cause of death on the battlefield, but a new, injectable material developed by team of researchers from Texas A&M University and the Massachusetts Institute of Technology could buy wounded soldiers the time they need to survive by preventing blood loss from serious internal injuries.

20 Nov 2014

Novel Nanoparticles Can Simultaneously Perform MRI and Fluorescent Imaging in Living Animals

MIT chemists have developed new nanoparticles that can simultaneously perform magnetic resonance imaging (MRI) and fluorescent imaging in living animals. Such particles could help scientists to track specific molecules produced in the body, monitor a tumor’s environment, or determine whether drugs have successfully reached their targets.

20 Nov 2014

Foreign Policy Magazine Honors Koch Institute Faculty Member as One of 100 Leading Global Thinkers

Koch Institute faculty member Sangeeta Bhatia has been selected as one of Foreign Policy magazine’s 100 Leading Global Thinkers of 2014 for her work in developing inexpensive and noninvasive diagnostics for the early detection of colon cancer.

20 Nov 2014

Biochemists Create Large Nanoscale Protein Container

UCLA biochemists have created the largest-ever protein that self-assembles into a molecular “cage.” The research could lead to synthetic vaccines that protect people from the flu, HIV and other diseases.

19 Nov 2014

Prototype of Skin Patch That Delivers Vaccine through Nanofibers Presented at Collegiate Inventors Competition

From the first-ever full, variable color 3D printing technology to a skin patch that can deliver a vaccine through nanofibers without a needle - the prototypes and research presented at the Collegiate Inventors Competition were nothing short of genius. After an intense and exciting deliberation between expert judges, the 2014 undergraduate and graduate winners have been selected.

18 Nov 2014

Nanomedicine News

Novavax' Nanoparticle Vaccine for Infant Protection via Maternal Immunization Granted FDA Fast Track Designation

Nanophosphor Biomarker Lights Up On Detecting Tumour Cells

Iron-Oxide Nanoparticles Can Successfully Detect Ovarian Tumors In Vivo

NanoViricides’ Injectable FluCide Drug among ‘Top Ten Infectious Diseases Projects to Watch’

BIND Reports Positive Results from BIND-014 Polymeric Nanoparticle Phase 2 Study in NSCLC

Biodegradable Gelatin Embedded with Nano-Sized Silicate Discs Aids in Blood Coagulation

Novel Nanoparticles Can Simultaneously Perform MRI and Fluorescent Imaging in Living Animals

Foreign Policy Magazine Honors Koch Institute Faculty Member as One of 100 Leading Global Thinkers

Biochemists Create Large Nanoscale Protein Container

Prototype of Skin Patch That Delivers Vaccine through Nanofibers Presented at Collegiate Inventors Competition

Combining Nanofluids and Turbulators for Sustainable Energy

Enhancing Material Properties through Nanotube Encapsulation

Brain-Inspired Nano-Tech Promises New Era for Electronics

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Sustainable Carbon Nanomaterial Gii Set to Transform Energy Storage in Internet of Things Devices

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials